Pipeline™ Flex Embolization Device With Shield Technology™ Clinical Study
NCT02390037 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2019-02-01
Summary
The objective of the study is to assess the incidence of safety outcomes in patients treated with Pipeline™ Flex embolization device with Shield Technology™.
Conditions
- Aneurysm
Sponsors & Collaborators
-
Medtronic Neurovascular Clinical Affairs
lead INDUSTRY
Principal Investigators
-
Edoardo Boccardi, M.D. · Ospedale Niguarda "Ca' Granda"
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2016-11-04
- Completion
- 2016-11-04
Countries
- Belgium
- Germany
- Greece
- Italy
- Spain
- United Kingdom
Study Locations
More Related Trials
-
Pivotal Study of the Medtronic Axys EX Rotational Atherectomy System
NCT04282161 ·Status: WITHDRAWN ·Phase: NA
-
Paclitaxel-coated Balloon Angioplasty Versus Standard Angioplasty for the Treatment of Stenosis of Arteriovenous Fistula
NCT02753998 ·Status: COMPLETED ·Phase: PHASE3
-
Zilver® Flex™ Vascular Stent Study
NCT00827619 ·Status: COMPLETED ·Phase: NA
-
"All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes
NCT02531230 ·Status: COMPLETED
-
A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection
NCT02501148 ·Status: COMPLETED
-
IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA
NCT02963649 ·Status: COMPLETED ·Phase: NA
-
The Clinical Application of Peripheral Embolization Coil Systems in Arteriovenous Embolization Within the Peripheral Vasculature
NCT07156409 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis
NCT02568293 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter.
NCT02939924 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
NCT01355406 ·Status: COMPLETED ·Phase: NA
-
Carotid Stenting in Patients With High Risk Carotid Stenosis ("Soft Plaque")
NCT01274676 ·Status: COMPLETED ·Phase: NA
-
Zilver® PTX™ Global Registry
NCT01094678 ·Status: COMPLETED ·Phase: NA
-
Balloon Angioplasty Versus Primary Stenting for the Treatment of Femoropopliteal Artery Chronic Total Occlusions
NCT01268722 ·Status: UNKNOWN ·Phase: PHASE3
-
Advance® 18PTX® Balloon Catheter Study
NCT00776906 ·Status: COMPLETED ·Phase: NA
-
PMCF Study for Peripheral Arteries Below the Knee (BTK)
NCT05444660 ·Status: COMPLETED
-
Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral And/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCB
NCT03676842 ·Status: TERMINATED ·Phase: NA
-
Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease
NCT01007578 ·Status: COMPLETED ·Phase: PHASE1
-
The Paclitaxel-Eluting Percutaneous Coronary Angioplasty (PTCA)-Balloon Catheter for the Treatment of Coronary Bifurcations
NCT01180517 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery
NCT01728441 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Paclitaxel in Patients With CLI and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty
NCT02758847 ·Status: COMPLETED ·Phase: NA
-
"All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Extended)
NCT02900274 ·Status: COMPLETED
-
Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery
NCT03040063 ·Status: UNKNOWN ·Phase: NA
-
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02522884 ·Status: COMPLETED ·Phase: NA
-
Retrospective Follow-up of BIOLUX P-I/-II
NCT04250909 ·Status: COMPLETED
-
The DETOUR 2 Clinical Trial
NCT03119233 ·Status: COMPLETED ·Phase: NA